Preliminary applications are now being accepted for PLCO EEMS Round 21 and for Funding Opportunity Announcement (PAR-15-297). For more information please visit https://biometry.nci.nih.gov/cdas/plco/
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
is a large population based randomized trial designed and sponsored by the National
Cancer Institute (NCI) to determine the effects of screening on cancer-related mortality
and secondary endpoints in men and women aged 55 to 74. The screening component
of the trial was completed in 2006. Participants are being followed and additional
data will be collected through 2015. Numerous epidemiologic and ancillary studies
are also underway to answer related crucial questions.
Learn more about PLCO, how to obtain access to study data and biospecimens, and
view additional information by accessing links below. Go to PLCO STaRS to complete
and submit all forms and applications for biospecimen requests. Access PLCO STaRS
by clicking the login button located on the upper right corner of this page.
If you do not have access to the PLCO STaRS site or have questions, contact the
PLCO Helpdesk at email@example.com.
Public use datasets can be found
at the Cancer Data Access System (CDAS).